US20080276935A1 - Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs - Google Patents

Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs Download PDF

Info

Publication number
US20080276935A1
US20080276935A1 US12/135,648 US13564808A US2008276935A1 US 20080276935 A1 US20080276935 A1 US 20080276935A1 US 13564808 A US13564808 A US 13564808A US 2008276935 A1 US2008276935 A1 US 2008276935A1
Authority
US
United States
Prior art keywords
acid
peg
polyglyceryl
β
laurate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/135,648
Inventor
Lixiao Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lutonix Inc
Original Assignee
Lutonix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US86008406P priority Critical
Priority to US88074207P priority
Priority to US89742707P priority
Priority to US90352907P priority
Priority to US90447307P priority
Priority to US92685007P priority
Priority to US98138007P priority
Priority to US98138407P priority
Priority to US11/942,459 priority patent/US20080175887A1/en
Application filed by Lutonix Inc filed Critical Lutonix Inc
Priority to US12/135,648 priority patent/US20080276935A1/en
Assigned to LUTONIX, INC. reassignment LUTONIX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WANG, LIXIAO
Publication of US20080276935A1 publication Critical patent/US20080276935A1/en
Application status is Abandoned legal-status Critical

Links